Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in ...
Rutgers‑led study of 2.2 million people finds addiction risk is driven more by genes tied to impulse control and reward ...
A landmark trial over “addictive” social media design is forcing a legal reckoning over whether tech addiction is real and ...
Clinical evidence has long suggested that the use of GLP-1 medications is linked to lower substance use. It’s also been ...
New research shows weight-loss drugs like semaglutide may also reduce mental health issues like depression, anxiety, and ...
A recent study published has identified a brain protein that may help explain why cocaine addiction is difficult to overcome.
Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process rewards, regulate impulses and weigh consequences – not from genes that ...
Cocaine addiction may persist because the drug rewires brain circuits through a protein called DeltaFosB. This buildup ...
Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring ...
A mouse study highlights the role of acetylcholine in behavioral flexibility, offering new insight into the brain mechanisms involved in addiction and obsessive compulsive disorder.
New York, March 16, 2026 (GLOBE NEWSWIRE) -- NEW YORK (March 16, 2026) -- The Brain & Behavior Research Foundation (BBRF) today announced it will award $1 million in Distinguished Investigator Grants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results